Literature DB >> 10667895

Psychosocial impact of type-specific herpes simplex serological testing on asymptomatic sexual health clinic attendees.

A Smith1, I Denham, L Keogh, D Jacobs, V McHarg, A Marceglia, V Wood.   

Abstract

The usefulness of type-specific testing for herpes simplex virus type 2 (HSV-2) is much debated with proponents arguing for likely change in the sexual behaviour of asymptomatic carriers and opponents suggesting that testing may have significant adverse psychological impact while not promoting behaviour change. In the present study we examine the impact of HSV-2 serological testing on psychological well-being, self-esteem, anxiety, sexual self-perceptions and sexual practices among a sample of 180 clients of a sexual health clinic. Of the participants, 21 (11.7%) were HSV-2 positive at entry to the study. No adverse psychological consequences of a positive test were observed among those participants followed for 3 months (n=124) or for 6 months (n=97). There was little significant change observed in sexual behaviour although a general but not significant pattern of decreased sexual behaviour with casual partners was observed among participants who tested HSV-2 negative. While supportive of the value of HSV-2 testing, these findings require replication in larger samples and different populations.

Entities:  

Mesh:

Year:  2000        PMID: 10667895     DOI: 10.1258/0956462001914841

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  12 in total

Review 1.  Sorting out the new HSV type specific antibody tests.

Authors:  R L Ashley
Journal:  Sex Transm Infect       Date:  2001-08       Impact factor: 3.519

Review 2.  Psychological symptoms associated with genital herpes virus infections: epidemiology and approaches to management.

Authors:  Adrian Mindel; Caron Marks
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

3.  The psychosocial impact of serological diagnosis of asymptomatic herpes simplex virus type 2 infection.

Authors:  S L Rosenthal; G D Zimet; J S Leichliter; L R Stanberry; K H Fife; W Tu; D I Bernstein
Journal:  Sex Transm Infect       Date:  2006-04       Impact factor: 3.519

4.  The psychosocial impact of serological herpes simplex type 2 testing in an urban HIV clinic.

Authors:  J L Meyer; R A Crosby; W L H Whittington; D Carrell; R Ashley-Morrow; A S Meier; R D Harrington; R DiClemente; A Wald
Journal:  Sex Transm Infect       Date:  2005-08       Impact factor: 3.519

5.  Genital herpes serotesting: a study of the epidemiology and patients' knowledge and attitude among STD clinic attenders in Coventry, UK.

Authors:  N Narouz; P S Allan; A H Wade; S Wagstaffe
Journal:  Sex Transm Infect       Date:  2003-02       Impact factor: 3.519

6.  Estimating the costs and benefits of screening monogamous, heterosexual couples for unrecognised infection with herpes simplex virus type 2.

Authors:  D N Fisman; E W Hook; S J Goldie
Journal:  Sex Transm Infect       Date:  2003-02       Impact factor: 3.519

7.  Serologic screening for herpes simplex virus among university students: a pilot study.

Authors:  Hayley Mark; Joy P Nanda; Alain Joffe; Jessica Roberts; Anne Rompalo; Johan Melendez; Jonathan Zenilman
Journal:  J Am Coll Health       Date:  2008 Nov-Dec

8.  HSV type specific serology in sexual health clinics: use, benefits, and who gets tested.

Authors:  B Song; D E Dwyer; A Mindel
Journal:  Sex Transm Infect       Date:  2004-04       Impact factor: 3.519

9.  Psychosocial impact of serological diagnosis of herpes simplex virus type 2: a qualitative assessment.

Authors:  J Melville; S Sniffen; R Crosby; L Salazar; W Whittington; D Dithmer-Schreck; R DiClemente; A Wald
Journal:  Sex Transm Infect       Date:  2003-08       Impact factor: 3.519

10.  Suppressive valacyclovir therapy to reduce genital herpes transmission: good public health policy?

Authors:  Paul E Bonnar
Journal:  Mcgill J Med       Date:  2009-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.